Please login to the form below

chronic diseases

This page shows the latest chronic diseases news and features for those working in and with pharma, biotech and healthcare.

Amgen raises forecasts after closing $13.4bn Otezla deal

As the prevalence of chronic inflammatory diseases increases worldwide, Otezla represents a unique opportunity to further Amgen's mission of bringing innovative medicines to patients, while building on our long-standing

Latest news

The end of pharma

Well, twice in recent weeks I’ve worked with companies in chronic diseases – diabetes and asthma.
Novo Nordisk taps Noom for digital help with its push into obesity

chronic diseases”.
Boehringer posts solid first half as business revamp beds in

Boehringer said in its interim results statement that it is anticipating further upward momentum if it can claim an approval for the SGLT2 inhibitor for people with chronic heart failure, with ... Meanwhile, Boehringer is also testing the impact of
FDA fast-tracks Jardiance for heart failure review

These studies look at empagliflozin’s impact on cardiovascular death and hospitalisation for heart failure in adults with chronic heart failure with reduced or preserved ejection fraction, respectively. ... Boehringer Ingelheim and Lilly are committed
Charity launches real-world medical cannabis study

However, it doesn’t include chronic pain, one of the main uses of cannabis products, and campaigners have said this makes the programme too restrictive. ... the off, including those with chronic pain and other diseases like multiple sclerosis, and

More from news
Approximately 2 fully matching, plus 171 partially matching documents found.

Latest Intelligence

The long and winding road to asthma breakthroughs

Early research in biologics for respiratory diseases did not fare well, with disappointing clinical trials and a danger that the promise would run out of steam. ... It also voiced patient concern that asthma and Chronic Obstructive Pulmonary Disease were
Delivering the promise of regenerative medicine

Marking a new era in healthcare and one which has the promise of addressing the needs of an ageing population challenged by escalating chronic diseases, regenerative medicine is certainly a game ... Regenerative medicine is poised to transform healthcare
Rare disease trials Q&A

With 350 million people affected worldwide, rare diseases represent a major unmet medical need. ... Characterised by small, highly heterogeneous patient populations, including children in almost half of the cases, rare diseases are usually genetic and
Is anybody listening?

Evidence shows that, in chronic disease areas, if you improve a patient’s knowledge, skills and confidence, those patients recover faster and live longer. ... The research says that online health communities have a major role to play in promoting
Innovation in merger control and the impact on the pharmaceutical sector

Specifically, Hospira was selling Inflectra, an infliximab biosimilar used to treat several chronic inflammatory diseases, notably the inflammation of Crohn’s disease, while Pfizer was in an advanced stage of developing

More from intelligence
Approximately 2 fully matching, plus 46 partially matching documents found.

Latest appointments

Kymab appoints its first chief medical officer

She has over 20 years of experience biomedical research and has focused on pathogenic mechanisms, underlying chronic inflammatory diseases and the interface between autoimmunity and cancer.
Dr Li Zhou joins TxCell as cell engineering VP

Dr Zhou will lead the team's discovery and engineering activities on Chimeric Antigen Receptor in Treg cells ( CAR-Treg) for immunotherapy of severe chronic autoimmune and inflammatory diseases and organ
Sanofi’s US pharma head joins Synta as CEO

She now leads an emerging US-based biopharma focused on the development of small molecule drugs to treat patients with severe medical conditions, including cancer and chronic inflammatory diseases.
Medgenics confirms appointment of Dr Marvin Garovoy

The company's Biopump uses a patient's own tissue to continuously produce and deliver their protein therapy and, potentially, has applications in a range of chronic diseases, including diabetes, multiple

More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest from PMHub

WHITE PAPER: Patient nonadherence – the $637bn paradox

In developed countries, adherence among patients suffering chronic diseases averages only 50%; levels in developing countries are thought to be considerably lower.[6] Given that nearly half of adults have a ... Multiple chronic conditions among US. adults
How Medisafe is using AI to improve patient adherence

instructions. The World Health Organisation (WHO) estimates that by 2020, chronic diseases will account for almost three-quarters of all deaths worldwide.
How Medisafe is using AI to improve patient adherence

instructions. The World Health Organisation (WHO) estimates that by 2020, chronic diseases will account for almost three-quarters of all deaths worldwide.
Irritable Bowel Syndrome (IBS) patient insights

However, as is the case with many chronic diseases the extent to which the disease impacts upon a patient’s quality of life is inadequately represented by considering the symptoms alone. ... 2) . "IBS is a chronic medical condition, although the
Wearables and healthcare

mid-twenties.[2] . Factors such as these, among others, have increased the prevalence of chronic diseases, which account for around 70% of the health service budget.[3, 4] To ensure the ... The outputs of this process are predictive algorithms that